BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace


Innophore logo



AI Companies (Drug Discovery)

Innophore uses a new and unique way to identify enzymes for existing or up-coming industrial biocatalytic processes. The CatalophoreTM platform enables companies to make ground breaking discoveries with an exclusive database of 3D enzyme cavities.
The CatalophoreTM platform is a digital search engine provided to industrial partners in the areas Pharmaceuticals, Fine and bulk chemicals, Biotherapeutics, Food & Beverage, Cosmetic, Industry or Molecular Diagnostics. Companies benefit from the application within finding altered protein properties such as thermo- and solvent stability, substrate spectrum, selectivity and specificity. Based on spacial features of active sites of enzymes, new in-silico methods are used to identify enzyme candidates using the CatalophoreTM platform, a combination of a comprehensive ready-to-use structural database of biomolecules and unique search algorithms and tailored patterns.

structural biology enzymology biocatalysis

Posts Mentioning This Company

How Pharma Reacts To Wuhan Coronavirus Outbreak

UPDATE April 04. 2020. The number of confirmed cases of COVID19 approaches 1M globally. Since too many drug repurposing programs and vaccine development projects have been urgently initiated, we decided to summarize them in a separate post: A Running List Of COVID-19 Treatments And Vaccines In Development With this, we …